Literature DB >> 1655448

Treatment of experimental murine Coxsackie B3 myocarditis.

M Herzum1, S A Huber, R Weller, R Grebe, B Maisch.   

Abstract

Using the murine model of coxsackievirus B3-induced myocarditis we studied the effects of various immunosuppressive agents on the course and outcome of the disease in genetically different strains of mice. The response to drug treatment varied greatly among the strains of inbred mice, which suggests different immune pathomechanisms operative in mediating myocarditis.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1655448     DOI： 10.1093/eurheartj/12.suppl_d.200

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


  6 in total

Review 1.  Influence of myocarditis on left ventricular function.

Authors:  K L Baughman
Journal:  Trans Am Clin Climatol Assoc       Date:  2000

2.  Clinical outcomes of acute myocarditis in childhood.

Authors:  K J Lee; B W McCrindle; D J Bohn; G J Wilson; G P Taylor; R M Freedom; J F Smallhorn; L N Benson
Journal:  Heart       Date:  1999-08       Impact factor: 5.994

3.  Coxsackievirus B3-induced myocarditis: perforin exacerbates disease, but plays no detectable role in virus clearance.

Authors:  J R Gebhard; C M Perry; S Harkins; T Lane; I Mena; V C Asensio; I L Campbell; J L Whitton
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

Review 4.  An approach to the treatment of pediatric myocarditis.

Authors:  Daniel Levi; Juan Alejos
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

5.  Cyclosporine A Treatment Inhibits Abcc6-Dependent Cardiac Necrosis and Calcification following Coxsackievirus B3 Infection in Mice.

Authors:  Jennifer Marton; Danica Albert; Sean A Wiltshire; Robin Park; Arthur Bergen; Salman Qureshi; Danielle Malo; Yan Burelle; Silvia M Vidal
Journal:  PLoS One       Date:  2015-09-16       Impact factor: 3.240

6.  Mycophenolate mofetil inhibits the development of Coxsackie B3-virus-induced myocarditis in mice.

Authors:  Elizaveta Padalko; Erik Verbeken; Patrick Matthys; Joeri L Aerts; Erik De Clercq; Johan Neyts
Journal:  BMC Microbiol       Date:  2003-12-21       Impact factor: 3.605
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.